Stocktoria
biote Corp. BTMD
Nasdaq · XNAS · stock · Medicinal Chemicals & Botanical Products · website · IPO 2021-03-02
Chart by TradingView
6/9
Piotroski F — financial health
0.92
Altman Z″ — distress risk · distress
6.4%
Dividend payout · safe
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $192.2M | $197.2M | $185.4M | $165.0M | $139.4M |
| Operating income | $35.6M | $31.6M | $28.7M | -$60.7M | $34.6M |
| Net income | $27.0M | $3.2M | $3.3M | -$969,000 | $11.1M |
| Operating cash flow | $35.2M | $45.2M | $26.9M | -$9.2M | $33.7M |
| Free cash flow | $30.2M | $38.8M | $26.5M | -$9.5M | $32.3M |
| Total assets | $107.6M | $122.4M | $155.3M | $111.6M | $54.3M |
| Total liabilities | $158.0M | $224.6M | $191.8M | $169.9M | $50.2M |
| Shareholders' equity | -$58.5M | -$102.2M | -$36.5M | -$58.3M | $4.1M |
| Ratios | |||||
| Operating margin | 18.5% | 16.0% | 15.5% | -36.8% | 24.8% |
| Net margin | 14.1% | 1.6% | 1.8% | -0.6% | 8.0% |
| FCF margin | 15.7% | 19.7% | 14.3% | -5.8% | 23.2% |
| Return on assets | 25.1% | 2.6% | 2.1% | -0.9% | 20.5% |
| Return on equity | -46.2% | -3.1% | -9.1% | 1.7% | 269.4% |
| Debt / equity | -1.64× | -0.99× | -2.92× | -1.92× | 7.75× |
| Current ratio | 1.22 | 1.32 | 5.51 | 5.39 | 2.72 |
| Revenue growth | -2.5% | 6.4% | 12.4% | 18.3% | — |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 265,916 | $358,987 |
Why these scores methodology →
Piotroski F-score: 6/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 0.92 (distress)
- Working capital / assets 0.09
- Retained earnings / assets -0.46
- EBIT / assets 0.33
- Equity / liabilities -0.37
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001819253 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.